Sign In

Amy Alkon

Amy Alkon is a highly accomplished professional with a diverse background in journalism, radio hosting, advising, and mediation.

She is an alumnus of both the University of Michigan and New York University, where she honed her expertise across various disciplines.

Amy is best known as a Science-Based Syndicated Advice Columnist, where she offers evidence-based guidance to her audience.

In addition to her column, she is a prolific author, sharing her insights on a wide range of topics to inform and entertain her readers.

Amy is also a seasoned radio host, bringing her unique perspective and engaging style to the airwaves through her programs.

Her skills extend beyond media as she serves as a mediator, utilizing her experience and diplomacy to facilitate positive resolutions.

Prior to her current endeavors, Amy Alkon held a role as a Producer at Ogilvy & Mather, illustrating her versatility and adaptability in the professional world.

Highlights

May 18 · twitter

This is not Harvard‘s research, as it seems many believe it to be. These are individual researchers who have labs there. Doing vital work that has been cut off in the middle. This harms all of us.

With research grants, there is money for overhead for the university, sure, but the funding is vitally necessary to do these big longitudinal studies.

No pharmaceutical company is going to pay for them. This research funded by the NIH and other foundations.

When people say Harvard should pay, that’s just not realistic. These universities will not fund this research, so demanding that they do is simply childish.

Nov 29 · twitter

No Jews to blame. Nobody cares.

A
Add to my network

Location

Santa Monica, California